Healthcare -
Biotechnology - NASDAQ - US
$ 1.74
6.75 %
$ 91.8 M
Market Cap
-0.59
P/E
ALXO - COST OF REVENUE
Cost of Revenue ALXO - ALX Oncology Holdings Inc.
836 K
LAST VALUE
6.58%
2 YEAR CAGR
-14.96%
5 YEAR CAGR
0.00%
10 YEAR CAGR